AWRE Chief Revenue Officer Brian J Krause bought 5,000 shares at $2.20 on 2025-08-29, doubling his holdings to 10,000 shares.
Krause purchased 5,000 shares at $2.20 on 2025-08-29, doubling his prior position from 5,000 to 10,000 shares. The purchase comes as the stock trades 15.0% below its 52-week high of $2.54 and 27.8% above its 90-day low. His prior trades at AWRE show mixed results: a March 2025 buy delivered -1.2% over 90 days, while another March 2025 buy returned +7.0%, with only 1 of 2 prior buys at this ticker proving well-timed at the 90-day mark. The company remains unprofitable with negative net income of $-1.8M in its latest quarter and annual revenue declined 4.7% year-over-year. This transaction expands an insider's stake in a company facing both profitability and growth headwinds.
CRO Brian J Krause buys 2,500 shares of AWRE at $1.69; stock now -41.1% from 52-week high in unprofitable company.
Krause, Chief Revenue Officer, purchased 2,500 shares at $1.69 on 2025-03-08, doubling his holdings to 5,000 shares. The acquisition occurred as AWRE trades 41.1% below its 52-week high and the company remains unprofitable with negative net income of -$1.6M on quarterly revenue of $3.6M and annual revenue declining 4.7% year-over-year. His prior open-market buy across all tickers averaged a -7.6% 30-day return, and his one prior buy at AWRE (2025-03-07) also showed a -7.6% 30-day return. The transaction represents a material increase in his position but occurs against a backdrop of deteriorating fundamentals and weak timing consistency in his purchase history.
CRO Brian Krause bought 2,500 shares of AWRE at $1.57; stock now $1.56, down 44.3% from 52-week high. Cluster buy pattern detected (2 other insiders also bought within 14 days).
Krause, Chief Revenue Officer, purchased his first position at AWRE (2,500 shares for $3,925.00) on 2025-03-07, at $1.57. The stock is now trading at $1.56, down 44.3% from its 52-week high of $2.80 and down 7.7% over the past 30 days. AWRE remains unprofitable (net income of $-1.2M in the latest quarter) despite 14.0% annual revenue growth and current quarterly revenue of $3.8M. The CRO's purchase occurs within a cluster window in which 2 other insiders also bought within the past 14 days. This multi-insider buying activity in a small-cap equity ($33.1M market cap) warrants investigation into whether the company's fundamentals or strategic positioning have changed, or whether other context (pricing, guidance) is driving insider accumulation during a period of price weakness.
